Owner Pfizer Inc.

Inventors Mowbray, Charles Eric; Price, Davis Anthony; Stupple, Paul Anthony; Jones, Lyn Howard; Selby, Matthew Duncan

Agent Spruson & Ferguson

Pub. Number AU-B-2002242926

PCT Pub. Number WO2002/085860

Priority 0108999.4 10.04.01 GB; 0127426.5 15.11.01 GB

Filing date 4 April 2002

Wipo publication date 5 November 2002

Acceptance publication date 11 October 2007

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4178 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/5377 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/683 (2006.01) - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 231/20 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/28 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings